Kathrine Roe
Nydalen, 0424, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma.
Journal: PloS one
Published: May 14, 2013
Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer.
Journal: International journal of radiation oncology, biology, physics
Published: May 07, 2013
Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts.
Journal: Nuclear medicine and molecular imaging
Published: April 07, 2013
Modifications in dynamic contrast-enhanced magnetic resonance imaging parameters after α-particle-emitting ²²⁷Th-trastuzumab therapy of HER2-expressing ovarian cancer xenografts.
Journal: International journal of radiation oncology, biology, physics
Published: January 15, 2013
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.
Journal: Radiation oncology (London, England)
Published: February 01, 2012
Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study.
Journal: Radiation oncology (London, England)
Published: February 01, 2011
Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 14, 2010
Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions.
Journal: Neoplasia (New York, N.Y.)
Published: March 26, 2010
Showing 1-10 of 10
Last Updated: 09/26/2026